T. Rowe Price Associates’s Kestra Medical Technologies KMTS Stock Holding History
Bought
Maintained
Sold
Other funds holding KMTS
YF
T. Rowe Price Associates's KMTS Position: Q3 2026 in Review
T. Rowe Price Associates increased its Kestra Medical Technologies (KMTS) stake by 7.5% in Q3 2026, buying an estimated $9.5M and bringing the position to 5,342,837 shares worth $151M. The position accounts for 0.02% of the portfolio, ranked #545.
T. Rowe Price Associates first reported a position in KMTS in Q1 2025 and has held it in 7 quarters since. 122 funds tracked by Wall St. Rank hold KMTS as of Q3 2026.
- T. Rowe Price Associates held 5,342,837 shares of Kestra Medical Technologies worth $151M as of Q3 2026.
- T. Rowe Price Associates bought 373,937 Kestra Medical Technologies shares in Q3 2026, an estimated $9.5M.
- Kestra Medical Technologies made up 0.02% of T. Rowe Price Associates's portfolio in Q3 2026, its #545 holding.
- T. Rowe Price Associates first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 7 quarters since.
- 122 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q3 2026.
Based on T. Rowe Price Associates's 13F filing for Q3 2026, filed 16 Nov 2026.